News

A research team has bioengineered a novel adhesive patch platform that can efficiently deliver blood vessel-forming growth factors using a bio-adhesive material that is made from mussels harmless to humans.

A team of researchers has combined a wide variety of data and developed a new algorithm using machine learning technology to identify 165 previously unknown cancer genes.

A "first-of-its-kind" study by researchers at Rutgers University and the University of Oslo has found that overfishing is not likely to be causing evolutionary changes and early maturation in the Atlantic cod fish population.

A new study has found that older adults who received positive airway pressure therapy prescribed for obstructive sleep apnea may be less likely to develop Alzheimer's disease and other kinds of dementia.

A new study describes antibodies capable of neutralizing tick-borne encephalitis (TBE). These so-called broadly neutralizing antibodies have shown promise in preventing TBE in mice and could inform the development of better vaccines for humans.

Researchers have described a new gene-editing technology called CRISPRoff that allows researchers to control gene expression with high specificity while leaving the sequence of the DNA unchanged. The method is stable enough to be inherited through hundreds of cell divisions, and is also fully reversible.

Researchers have demonstrated that different viruses can lead to brain malformations through diverse mechanisms by using human brain organoid models.

Studies on pollution, respiratory and health disparities have been reviewed and ambient air pollution has been shown to worsen viral respiratory infections. Now, a similar association between ambient air pollution and worse COVID-19 outcomes has been shown.

A study has revealed that the pH of milk should be considered in looking at ways to improve sheep's milk cheese production and yield.

Researchers have unveiled a novel feature of COVID-19 immunity, which could have implications for future therapies. The study points to the involvement of Interleukin 33 when immune cells encounter Sars-CoV-2 for a second time.